Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Mallinckrodt, the pharmaceuticals business of Covidien, has launched its morphine sulfate oral solution for the relief of moderate-to-severe acute and chronic pain in opioid-tolerant patients.
Subscribe to our email newsletter
The solution is the generic morphine oral solution to be approved by the FDA and is available in 100 milligrams per 5mL (20 milligrams per 1mL).
Morphine sulfate oral solution 100mg per 5mL (20mg/mL) is an opioid analgesic indicated for the relief of moderate to severe acute and chronic pain in opioid-tolerant patients.
The product is being launched with new packaging, including a plastic syringe dispenser with stopper that helps prevent spills, the company said.
Mallinckrodt interim chief medical officer Alfredo Bozzini said Morphine sulfate oral solution will provide a treatment option for patients who are opioid-tolerant and living with pain.